Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (16297)	10/2/2003 9:08:30 AM
From: aknahow	Read Replies (2) \| Respond to of 17367

Yes. Read the information again. Neuprex works and these pilot probe studies are going to show that it does. Then it is going to be very difficult for regulators to prevent doctors using a safe drug to save little children. True I do wish Xoma would say more about what a pilot probe study entails. This is the first in a series, and Baxter chewed up time, doing nothing. But again since this is the first, shareholders should be told more about what such "probes" consist of.